Skip to main content

Table 3 General conditions and HBV infection of infants in the 3 groups

From: Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission

  Group A Group B Group C P
Sujects, n 62 61 65  
Gestational age, wk 39.1 ± 1.1 39.2 ± 1.2 39.0 ± 1.1 0.613
Weight, g 3465.78 ± 408.5 3475.4 ± 398.4 3468.6 ± 401.3 0.991
Length, cm 50.4 ± 1.1 50.5 ± 1.3 50.6 ± 1.4 0.677
Head circumference, cm 33.5 ± 1.2 33.7 ± 1.1 33.3 ± 1.3 0.179
Apgar score 9.95 ± 0.2 9.97 ± 0.17 9.98 ± 0.18 0.648
HBV infection, n(%) 0 0 12(18.4) <0.001